Cytokinetics, Incorporated company logo
Cytokinetics, Incorporated logo

Cytokinetics, Incorporated (CYTK) Selling, General & Administrative Expenses

Annual SG&A

$0.00$215.31M-100.00%

Summary

Current Value
As of today, CYTK annual SG&A is $0.00, down -100.00% on
Historical Performance
CYTK annual SG&A is down -100.00% over the past 3 years, down -100.00% over the past 5 years
All-Time High Comparison
CYTK annual SG&A is currently -100.00% below its historical high of $215.31M set on
3-Year Low Comparison
CYTK annual SG&A vs 3-year low value is unknown
Sector Comparison
CYTK annual SG&A is higher than 59.80% of companies in Healthcare sector

SG&A Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

CYTK Performance
MetricDateValue1Y3Y5Y15Y
$0.00-100.0%-100.0%-100.0%-100.0%
$91.72M+47.1%+70.0%+559.5%+2469.3%
-$12.65B-5975.6%-7208.3%-10000.0%-10000.0%
Price$62.95+44.9%+78.2%+153.2%+719.7%
$612.26M+12.3%+49.2%+551.7%+1116.9%
-$612.26M-14.2%-88.8%-551.7%-1133.5%
$10.13M+6.2%+20.6%+453.0%+432.9%
$88.04M+376.6%-6.9%+57.7%+3316.3%

SG&A Highs

CYTK Annual SG&A Highs Comparison
PeriodHighDateCurrent
3Y$215.31M-100.0%
5Y$215.31M-100.0%
All$215.31M-100.0%

SG&A Lows

CYTK Annual SG&A Lows Comparison
PeriodLowDateCurrent
3Y$0.00N/A
5Y$0.00N/A
All$0.00N/A

SG&A History

YearValueChange
$0.00-100.0%
$215.31M+24.0%
$173.61M-2.5%
$177.98M+83.9%
$96.80M+83.3%
$52.82M+33.4%
$39.61M+26.6%
$31.28M-14.2%
$36.47M+31.1%
$27.82M+41.5%
$19.67M+13.9%
$17.27M+14.4%
$15.09M+21.4%
YearValueChange
$12.43M-8.5%
$13.59M-4.3%
$14.20M-9.1%
$15.63M+3.6%
$15.08M-9.8%
$16.72M+9.7%
$15.24M+17.5%
$12.98M+8.2%
$11.99M+30.9%
$9.16M+31.8%
$6.95M+17.9%
$5.90M+74.0%
$3.39M-

FAQ

  • What is the current annual SG&A of CYTK?

    As of today, CYTK annual SG&A is $0.00

  • What is 1-year change in CYTK annual SG&A?

    CYTK annual SG&A is down -100.00% year-over-year

  • What is 3-year change in CYTK annual SG&A?

    CYTK annual SG&A is down -100.00% over the past 3 years

  • How far is CYTK annual SG&A from its all-time high?

    CYTK annual SG&A is currently -100.00% below its historical high of $215.31M set on December 31, 2024

  • How does CYTK annual SG&A rank versus sector peers?

    CYTK annual SG&A is higher than 59.80% of companies in Healthcare sector

  • When is CYTK next annual earnings release?

    As of today, the next annual earnings release for CYTK has not been scheduled

Selling, General & Administrative Expenses Formula

SG&A = − R&D

Data Sources & References

  1. CYTK Official Website www.cytokinetics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm
  4. CYTK Profile on Yahoo Finance finance.yahoo.com/quote/CYTK
  5. CYTK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cytk